Early results of a randomized trial of rifampicin-bonded Dacron grafts for extra-anatomic vascular reconstruction

British Journal of Surgery

Volumn 85, Issue 10, 1998, Pages 1378-1381

  Braithwaite, B D ^b   Davies, B ^b   Heather, B P ^b   Earnshaw, J J ^a  

^a GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GELATIN; RIFAMPICIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DACRON IMPLANT; FEMALE; GRAFT INFECTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULAR SURGERY; VEIN BYPASS;

AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTITUBERCULAR; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; POLYETHYLENE TEREPHTHALATES; PROSTHESIS-RELATED INFECTIONS; RIFAMPIN;

EID: 0031695574     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.1998.00878.x     Document Type: Article

References (22)

1. Bandyk DF, Esses GE. Prosthetic graft infection. Surg Clin North Am 1994; 74: 571-90.
2. Strachan CJL. Antibacterial prophylaxis in peripheral vascular and orthopaedic prosthetic surgery. J Antimicrob Chemother 1993; 31(Suppl. B): 65-78.
3. Gahtan V, Esses GE, Bandyk DF, Nelson RT, Dupont E, Mills JL. Antistaphylococcal activity of rifampicin-bonded gelatin-impregnated Dacron grafts. J Surg Res 1995; 58: 105-10.
4. Freyrie A, Curti T, Rodio M, Masetti L, Bignozzi L, Sanguinetti V et al. Interaction between vascular prostheses and rifampicin in the prevention of the grafts infection. An experimental study. Int Angiol 1992; 11: 113-16.
5. Lachapelle K, Graham AM, Symes JF. Antibacterial activity, antibiotic retention, and infection resistance of a rifampicin-impregnated gelatin-sealed Dacron graft. J Vasc Surg 1994; 19: 675-82.
6. Strachan CJL, Newsom SWB, Ashton TR. The clinical use of an antibiotic-bonded graft. Eur J Vasc Surg 1991; 5: 627-32.
7. Pons VG, Wurtz R. Vascular graft infections: a 25-year experience of 170 cases. J Vasc Surg 1991; 13: 751-3.
8. Campbell WB, Tambeur LJMT, Greens VR. Local complications after arterial bypass grafting. Ann R Coll Surg Engl 1994; 76: 127-31.
9. Szilagyi DE, Smith RF, Elliott JP, Vrandecic MP. Infection in arterial reconstruction with synthetic grafts. Ann Surg 1972; 176: 321-33.
10. D'Addato M, Curti T, Freyrie A. The rifampicin-bonded Gelseal graft. Eur J Vasc Endovasc Surg 1997; 14(Suppl. A): 15-17.
11. D'Addato M, Curti T, Freyrie A. Prophylaxis of graft infection with rifampicin bonded Gelseal graft: 2-year follow-up of a prospective clinical trial. Italian Investigators Group. Cardiovasc Surg 1996; 4: 200-4.
12. Jones L, Braithwaite BD, Davies B, Heather BP, Earnshaw JJ. Mechanism of late prosthetic vascular graft infection. Cardiovasc Surg 1997; 5: 486-9.
13. Hajjar GE. Graft materials. In: Moore WS, Gelabert HA, eds. Antibiotic-impregnated Vascular Grafts. Austin, Texas: RG Landes, 1993: 62-71.
14. Avramovic JR, Fletcher JP. Rifampicin impregnation of a protein-sealed Dacron graft: an infection-resistant prosthetic vascular graft. Aust N Z J Surg 1991; 61: 436-40.
15. D'Addato M, Curti T, Freyrie A, Agus GB, Bertini D, Biasi G. Prevention of early graft infection with rifampicin-bonded Gelseal grafts: a multicentre experimental study. Cardiovasc Surg 1994; 2: 254-8.
16. Goeau-Brissonniere O, Leport C, Bacourt F, Lebrault C, Comte R, Pechere J-C. Prevention of vascular graft infection by rifampicin bonding to a gelatin-sealed Dacron graft. Ann Vasc Surg 1991; 5: 408-12.
17. Goeau-Brissonniere O, Mercier F, Nicolas MH, Bacourt F, Coggia M, Lebrault C et al. Treatment of vascular graft infection by in situ replacement with a rifampicin-bonded gelatin-sealed Dacron graft. J Vasc Surg 1994; 19: 739-41.
18. Lundell A, Bergqvist D, Lindblad B, Leide S. The acute thrombogenicity of an infection-resistant rifampicin-soaked Dacron graft: an experimental study in sheep. Eur J Vasc Surg 1992; 6: 403-7.
19. Sardelic F, Ao PY, Fletcher JP. Rifampicin impregnated Dacron grafts: no development of rifampicin resistance in an animal model. Eur J Vasc Endovasc Surg 1995; 9: 314-18.
20. Naylor AR, Clark S, London NJM, Sayers RD, Macpherson DS, Barrie WW et al. Treatment of major aortic graft infection: preliminary experience with total graft excision and in situ replacement with a rifampicin bonded prosthesis. Eur J Vasc Endovasc Surg 1995; 9: 252-6.
21. Gupta AK, Bandyk DF, Johnson BL. In situ repair of mycotic abdominal aortic aneurysms with rifampicin-bonded gelatin-impregnated Dacron grafts: a preliminary case report. J Vasc Surg 1996; 24: 472-6.
22. Earnshaw JJ. Conservative surgery for aortic graft infection. Cardiovasc Surg 1996; 4: 570-2.